Discover the Cipla Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock.

Discover the Cipla Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock.

Mumbai: Pharmaceutical giants Cipla and Alkem Laboratories are in the final stages of a bidding war to acquire a controlling ...

India's largest stent manufacturer, Sahajanand Medical Technologies is also reportedly exploring a public listing on the domestic market ...

Citi’s commentary comes as China-based pharma company Jiangsu Hengrui has received approval for Paclitaxel, the generic ...

While Citi has maintained its 'buy' call for Cipla, it noted that a further delay in resolving issues at the Goa facility ...

DoP directs NPPA to recalculate ceiling prices of three antibiotics based on Cipla's applications: Gireesh Babu, New Delhi Thursday, October 17, 2024, 08:00 Hrs [IST] The Departme ...

The Nifty Pharma index has so far this year gained 54.42 percent while the benchmark Nifty advanced 26.94 percent in the same ...

Cipla’s stock remains in a strong uptrend despite recent dips, with potential to rise to ₹1,800-₹1,850 this quarter and ...

A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.

This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.

India’s evolving consumer landscape presents new opportunities for brands to tap into the growing wellness trend and meet the ...